A significant unmet need for treatments for #CriticalLimbIschemia (CLI) exists in the US. Israeli company @Pluristem believes it has the answer.
Reporting by @LanC_02https://www.jpost.com/HEALTH-SCIENCE/Israeli-cell-therapy-demand-could-be-worth-2-billion-by-2023-616747 …
0 replies
4 retweets
8 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
